What is the current Global Cholera Vaccines Market size?

The Global Cholera Vaccines Market is projected to register a CAGR of 9.80% during the forecast period (2024-2029) Read More

Who are the key players in Global Cholera Vaccines Market?

Sanofi, GlaxoSmithKline LLC, Astellas Pharma Inc, Pfizer Inc. and Merck & Co. Inc. are the major companies operating in the Global Cholera Vaccines Market. Read More

Which is the fastest growing region in Global Cholera Vaccines Market?

North America is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Cholera Vaccines Market?

In 2024, the Asia Pacific accounts for the largest market share in Global Cholera Vaccines Market. Read More

What years does this Global Cholera Vaccines Market cover?

The report covers the Global Cholera Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Cholera Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cholera Vaccines Market Size & Share Analysis - Industry Research Report

Cholera Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Cholera Vaccines Market is segmented by Vaccine Type (Whole cell V. cholerae O1 with Recombinant B-subunit, Killed Oral O1, and O139), Product (Vaxchora, Dukoral, Shanchol, and Other Products), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Cholera Vaccines Industry Overview

The cholera Vaccine market is highly fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Some of the significant companies in the market are Astellas Pharma Inc., Emergent BioSolutions Inc., GlaxoSmithKline plc (GSK), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Sanofi, Takeda Pharmaceutical Co. Ltd, Valneva SE, PaxVax Inc., and Pfizer Inc.